CONSORTIUM OVERVIEW

Our consortium agreement is designed to facilitate the speedy exchange of reagents and information for research collaboration with academics across Cambridge. Each industry partner within the Milner Therapeutics Consortium has set aside funds for collaborative projects, which are open to any therapeutic area and are expected to lead to joint publications.

Launch36

CONSORTIUM

CURRENT PROJECTS & CASE STUDIES

Launch36

CONSORTIUM CALL 2022